The intersection of climate change with chronic disease and healthcare infrastructure creates a critical and underreported ...

Sibeprenlimab, a monoclonal antibody, is the only IgA nephropathy treatment option to selectively inhibit the activity of a ...

The U.S. Food and Drug Administration has approved Otsuka's injectable drug to treat patients with a potentially ...

Discover the hidden signs of kidney disease that go beyond just changes in urination. Learn about the early warning signs and ...

The U.S. Food and Drug Administration has approved Otsuka's injectable drug to treat patients with a potentially ...

Learn how to detect kidney disease early with four essential tests highlighted by nephrologist Dr. Arjun Sabharwal.

Akebia filed its Investigational New Drug Application with the U.S. Food and Drug Administration (FDA) and recently initiated ...

The Centers for Medicare and Medicaid Services will cut short a big experiment to try and change the way dialysis is done in ...

A specially engineered antibody that can infiltrate kidney cysts has shown the ability to block key growth signals driving ...

The Ministry of Health (MOH) has received RM21 million in excise duty from sugar-sweetened beverages (SSBs) for the ...

Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results. Will dialysis and organ transplants become a thing of the past?

If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under 10 secondsWould potentially provide a cost-effective and ...